Considerations on antithrombotic treatment of VTE and AF patients

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Results with novel FXI inhibitor in AF set the stage for phase 3 trials
Results with novel FXI inhibitor in AF set the stage for phase 3 trials
AHA 2023
Results with novel FXI inhibitor in AF set the stage for phase 3 trials
- Christian Ruff, MD
Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
AHA 2023
Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
- Jeff Healey, MD
New diagnostic strategy to improve early CVD diagnosis in primary care patients with COPD or T2D
New diagnostic strategy to improve early CVD diagnosis in primary care patients with COPD or T2D
ESC Congress 2023
New diagnostic strategy to improve early CVD diagnosis in primary care patients with COPD or T2D
- Amy Groenewegen, MD
Colchicine fails to reduce perioperative AF or MI in patients undergoing major thoracic surgery
Colchicine fails to reduce perioperative AF or MI in patients undergoing major thoracic surgery
ESC Congress 2023
Colchicine fails to reduce perioperative AF or MI in patients undergoing major thoracic surgery
- David Conen, MD